• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童活体肝移植治疗线粒体疾病:DGUOK 缺陷的良好结局?

Pediatric liver transplantation from a living donor in mitochondrial disease: Good outcomes in DGUOK deficiency?

机构信息

Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

出版信息

Pediatr Transplant. 2020 Jun;24(4):e13714. doi: 10.1111/petr.13714. Epub 2020 Apr 22.

DOI:10.1111/petr.13714
PMID:32320107
Abstract

DGUOK deficiency is an autosomal recessive mitochondrial disorder characterized by hepatic and neurological manifestations. In patients with liver failure, the decision to perform LT can be difficult due to the likelihood of progressive neurological disease. We present a case of a 9-month-old boy who had DGUOK deficiency (E227K/R118H genotype) intact neurological status and liver failure. His MRI indicated extensive white matter changes, which created hesitation to perform LT. After a multidisciplinary evaluation, he underwent LT from a living donor at 11 months of age. Six years post-transplant, he has had no significant complications and no progression of neurological symptoms. Our case supports that even in the presence of neurological MRI findings, but in the absence of significant neurological symptoms, LT represents a viable option in DGUOK-deficient patients who have the E227K/R118H mutation combination along with liver failure.

摘要

DGUK 缺乏症是一种常染色体隐性遗传的线粒体疾病,其特征为肝脏和神经系统表现。在肝功能衰竭的患者中,由于进展性神经疾病的可能性,进行 LT 的决策可能较为困难。我们报告了一例 9 月龄男孩,患有 DGUK 缺乏症(E227K/R118H 基因型),但神经状态完整,且伴有肝功能衰竭。他的 MRI 显示广泛的白质改变,这使得进行 LT 犹豫不决。经过多学科评估,他在 11 个月大时接受了活体供者的 LT。移植后 6 年,他没有出现明显的并发症,也没有出现神经症状的进展。我们的病例支持了这样一种观点,即在存在神经 MRI 发现的情况下,但没有明显的神经症状,对于伴有 E227K/R118H 突变组合和肝功能衰竭的 DGUK 缺乏症患者,LT 是一种可行的选择。

相似文献

1
Pediatric liver transplantation from a living donor in mitochondrial disease: Good outcomes in DGUOK deficiency?儿童活体肝移植治疗线粒体疾病:DGUOK 缺陷的良好结局?
Pediatr Transplant. 2020 Jun;24(4):e13714. doi: 10.1111/petr.13714. Epub 2020 Apr 22.
2
Acute liver failure due to DGUOK deficiency-is liver transplantation justified?由于 DGUOK 缺乏导致的急性肝衰竭——是否有必要进行肝移植?
Clin Res Hepatol Gastroenterol. 2021 Jan;45(1):101408. doi: 10.1016/j.clinre.2020.02.018. Epub 2020 Apr 8.
3
Long-term outcomes after liver transplantation for deoxyguanosine kinase deficiency: a single-center experience and a review of the literature.脱氧鸟苷激酶缺乏症肝移植后的长期预后:单中心经验及文献综述
Liver Transpl. 2014 Apr;20(4):464-72. doi: 10.1002/lt.23830. Epub 2014 Feb 25.
4
Considerations for liver transplantation in deoxyguanosine kinase deficiency: A case series and review of the literature.考虑去氧鸟苷激酶缺乏症患者行肝移植:病例系列及文献复习。
Pediatr Transplant. 2024 Feb;28(1):e14670. doi: 10.1111/petr.14670. Epub 2023 Dec 27.
5
Favorable Outcome after Liver Transplantation in an Infant with Liver Failure Due to Deoxyguanosine Kinase Deficiency.一名因脱氧鸟苷激酶缺乏导致肝衰竭的婴儿肝移植后预后良好。
J Clin Med. 2024 Sep 10;13(18):5356. doi: 10.3390/jcm13185356.
6
Clinical and molecular basis of hepatocerebral mitochondrial DNA depletion syndrome in Japan: evaluation of outcomes after liver transplantation.日本肝性脑线粒体 DNA 耗竭综合征的临床和分子基础:肝移植后结局评估。
Orphanet J Rare Dis. 2020 Jul 24;15(1):169. doi: 10.1186/s13023-020-01441-5.
7
Living donor liver transplantation for ornithine transcarbamylase deficiency.活体供肝移植治疗鸟氨酸转氨甲酰酶缺乏症。
Pediatr Transplant. 2011 Jun;15(4):390-5. doi: 10.1111/j.1399-3046.2011.01494.x. Epub 2011 Mar 9.
8
Complete recovery from fulminant hepatic failure with severe coma by living donor liver transplantation.活体供肝移植使暴发性肝衰竭伴严重昏迷患者完全康复。
Hepatogastroenterology. 2003 Mar-Apr;50(50):515-8.
9
Complete Recovery of Oxysterol 7α-Hydroxylase Deficiency by Living Donor Transplantation in a 4-Month-Old Infant: the First Korean Case Report and Literature Review.4 月龄婴儿接受活体供者肝移植治疗完全康复:首例韩国病例报告及文献复习。
J Korean Med Sci. 2018 Nov 22;33(51):e324. doi: 10.3346/jkms.2018.33.e324. eCollection 2018 Dec 17.
10
Donor graft does not affect the P450 2C19 genotype expressed in peripheral blood in recipients of living donor liver transplantation.供体移植物不影响活体肝移植受者外周血中表达的 P450 2C19 基因型。
Clin Transplant. 2010 Nov-Dec;24(6):830-4. doi: 10.1111/j.1399-0012.2010.01220.x.

引用本文的文献

1
Favorable Outcome after Liver Transplantation in an Infant with Liver Failure Due to Deoxyguanosine Kinase Deficiency.一名因脱氧鸟苷激酶缺乏导致肝衰竭的婴儿肝移植后预后良好。
J Clin Med. 2024 Sep 10;13(18):5356. doi: 10.3390/jcm13185356.
2
Deoxyguanosine kinase deficiency: natural history and liver transplant outcome.脱氧鸟苷激酶缺乏症:自然病史及肝移植结局
Brain Commun. 2024 May 6;6(3):fcae160. doi: 10.1093/braincomms/fcae160. eCollection 2024.
3
Red Flags in Primary Mitochondrial Diseases: What Should We Recognize?原发性线粒体疾病的“危险信号”:我们应该识别什么?
Int J Mol Sci. 2023 Nov 25;24(23):16746. doi: 10.3390/ijms242316746.
4
Mitochondrial DNA maintenance defects: potential therapeutic strategies.线粒体 DNA 维持缺陷:潜在的治疗策略。
Mol Genet Metab. 2022 Sep-Oct;137(1-2):40-48. doi: 10.1016/j.ymgme.2022.07.003. Epub 2022 Jul 6.
5
Therapeutic Approaches to Treat Mitochondrial Diseases: "One-Size-Fits-All" and "Precision Medicine" Strategies.治疗线粒体疾病的方法:“一刀切”与“精准医学”策略
Pharmaceutics. 2020 Nov 11;12(11):1083. doi: 10.3390/pharmaceutics12111083.